ADME pharmacogenetics: future outlook for Russia

Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy

(2018) Elena Z. Golukhova et al.   CARDIOLOGY

Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendations

(2018) Jasmine A Luzum et al.   PHARMACOGENOMICS

Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers

(2018) Michael S. Zastrozhin et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Polymorphisms of CYP2C8 , CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population

(2017) Alexey Polonikov et al.   GENE

Genetic Polymorphisms of Cytochrome P450 Enzymes and Transport Proteins in a Russian Population and Three Ethnic Groups of Dagestan

(2017) Karin B. Mirzaev et al.   Genetic Testing and Molecular Biomarkers

Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy

(2017) E. F. Muslimova et al.   TERAPEVTICHESKII ARKHIV

CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects

(2016) S. A. Ivanova et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

The possibility of selecting optimal antiplatelet therapy in patients with coronary heart disease in terms of CYP2C19 polymorphism

(2016) O. L. Bockeria et al.   TERAPEVTICHESKII ARKHIV

Clopidogrel Response Variability

(2015) Elena Z. Golukhova et al.   AMERICAN JOURNAL OF THERAPEUTICS

Comparison of delivery strategies for pharmacogenetic testing services

(2014) Susanne B. Haga et al.   Pharmacogenetics and Genomics

Personalized Medicine and Human Genetic Diversity

(2014) Y.-F. Lu et al.   Cold Spring Harbor Perspectives in Medicine

Functional polymorphisms in the CYP1A1, ACE, and IL-6 genes contribute to susceptibility to community-acquired and nosocomial pneumonia

(2013) Lyubov E. Salnikova et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

CYP1A1, GCLC, AGT, AGTR1 gene–gene interactions in community-acquired pneumonia pulmonary complications

(2013) Lyubov E. Salnikova et al.   MOLECULAR BIOLOGY REPORTS

Association of cytochrome P450 genetic polymorphisms with neoadjuvant chemotherapy efficacy in breast cancer patients

(2012) Tatyana A Seredina et al.   BMC Medical Genetics

Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients

(2012) Ruijuan Liang et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Microarray-Based Detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 Allele Frequencies in Native Russians

(2010) Olga Gra et al.   Genetic Testing and Molecular Biomarkers

Practical recommendations for pharmacogenomics-based prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics

(2010) Laurent Becquemont et al.   PHARMACOGENOMICS

A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function

(2009) King Leung Fung et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene–gene and gene–environment interactions for disease susceptibility

(2009) Alexey V Polonikov et al.   JOURNAL OF HUMAN GENETICS

Cytochrome P450 2D6

(2009) Ryan P. Owen et al.   Pharmacogenetics and Genomics

CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction

(2008) Ksenia Goryachkina et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes

(2008) Oksana Makeeva et al.   PHARMACOGENOMICS

Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients

(2007) Olga A. Gra et al.   AMERICAN JOURNAL OF HEMATOLOGY